Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-FR | Version v4-EN | |
---|---|---|
Language | French | English |
Date Updated | 2020-09-24 | 2020-09-23 |
Drug Identification Number | 02246624 | 02246624 |
Brand name | COVERSYL | COVERSYL |
Common or Proper name | COVERSYL | COVERSYL |
Company Name | SERVIER CANADA INC | SERVIER CANADA INC |
Ingredients | PERINDOPRIL ERBUMINE | PERINDOPRIL ERBUMINE |
Strength(s) | 8MG | 8MG |
Dosage form(s) | TABLET | TABLET |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | 100 tablets | 100 tablets |
ATC code | C09AA | C09AA |
ATC description | ACE INHIBITORS, PLAIN | ACE INHIBITORS, PLAIN |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2020-09-17 | 2020-09-17 |
Estimated end date | 2020-09-28 | 2020-09-28 |
Actual end date | 2020-09-23 | 2020-09-23 |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | The expiry date of the available stock is less that 9 month (02/2021) which is not acceptable by our clients | The expiry date of the available stock is less that 9 month (02/2021) which is not acceptable by our clients |
Health Canada comments |